NCT04915183 2026-03-09
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
Clinical Trials
3 trialsNCT00335504 2017-02-15
Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia
National Cancer Institute (NCI)
Phase 2 Completed
NCT00637481 2016-12-29
A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer
National Cancer Institute (NCI)
Phase 1 Completed